Royal Bank Of Canada Synlogic, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.42 - $0.68 $635 - $1,028	1,513 Added 9.52%	17,413 $7,000
Q1 2023 May 15, 2023	BUY	$0.56 - $1.07 $448 - $856	800 Added 5.3%	15,900 $10,000
Q4 2022 Feb 14, 2023	BUY	$0.58 - $17.99 $2,593 - $80,433	4,471 Added 42.06%	15,100 $11,000
Q3 2022 Nov 14, 2022	BUY	$0.91 - $14.63 $162 - $2,618	179 Added 1.71%	10,629 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.89 - $2.47 $8,410 - $23,341	9,450 Added 945.0%	10,450 $12,000
Q1 2022 May 16, 2022	BUY	$1.63 - $2.55 $1,630 - $2,550	1,000 New	1,000 $2,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.